S&P・Nasdaq 本質的価値 お問い合わせ

Lite Strategy, Inc. LITS NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
50/100
1/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Lite Strategy, Inc. (LITS) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

アナリスト予想 一株当たり利益(EPS) $3.62 および 売上高 $0.07B 来期予想.

一株当たり利益(EPS)実績推移: 2024: 実績 $2.67 vs 予想 $3.62 (下回る -26.2%). 2025: 実績 $-2.39 vs 予想 $-6.28 (上回る +61.9%). アナリスト精度: 1%.

EPS予測 — LITS

1%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual $2.67 vs Est $3.62 ▼ 35.6% off
2025 Actual –$2.39 vs Est –$6.28 ▲ 162.8% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. Analysts expect the company to turn profitable.

売上高予測 — LITS

100%
Analyst Accuracy
Accurate
1 year compared
Actual vs Estimate
2024 Actual $0.065B vs Est $0.065B ▼ 0.0% off
Revenue Trend
Revenue has declined over the period shown. Analysts expect stable revenue going forward.
お問い合わせ
🎓
SharesGrow アカデミー
本質的価値の計算と割安株の見つけ方を学ぶ。
毎週のライブセッション
メッセージを送る